Core Faculty
Herbert Kim Lyerly, MD
Contact
Focus Areas
Degree
MD, University of California at Los Angeles
Dailey GP, Rabiola CA, Lei G, Wei J, Yang X-Y, Wang T, et al. Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer. Hum Vaccin Immunother. 2024 Dec 31;20(1):2309693.
Ginzel JD, Chapman H, Sills JE, Allen EJ, Barak LS, Cardiff RD, et al. Nonlinear progression during the occult transition establishes cancer lethality. 2024.
Trotter TN, Wilson A, McBane J, Dagotto CE, Yang X-Y, Wei J-P, et al. FIGURE 2 from Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice. 2024.
